Abstract
Recent studies have generated data demonstrating significant clinical activity of alpha-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkins lymphomas, multiple myelomatosis and hairy cell leukaemia.
| Original language | English (Ireland) |
|---|---|
| Number of pages | 4 |
| Journal | HNO |
| Volume | 2 |
| Issue number | 6 |
| Publication status | Published - 1 Dec 1991 |
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Giles FJ, Ozer H